Key Facts
• September 9: Draft plan presented to the Liberal Democratic Party’s health committee.
• 2023: Plan based on the Genome Medicine Act passed in June.
• Goal: Achieve world-class genome medicine standards by addressing ethics and discrimination.
• Three pillars: Public awareness, medical infrastructure, and research development.
• Public awareness: Human rights consultation systems to be established by year-end.
• Medical infrastructure: Centralized medical institutions and inter-hospital collaboration planned.
• Research development: Database creation and training for genome-related professionals.
• Educational materials: To be used in schools and workplaces nationwide from 2026.
• Target: Cabinet approval by the end of 2025.
Summary
The Japanese government has revealed a draft plan to promote genome medicine, aiming for cabinet approval by the end of 2025. The plan, based on the 2023 Genome Medicine Act, focuses on ethical considerations, preventing discrimination, and advancing research. It outlines three key pillars: raising public awareness, improving medical infrastructure, and fostering research development. Measures include establishing consultation systems for human rights, creating centralized medical institutions, and building a genome database. Educational materials will be introduced in schools and workplaces starting in 2026. The initiative seeks to achieve world-class standards in genome medicine while respecting individual rights and addressing ethical concerns.
